Sanofos IV

Sanofos IV Adverse Reactions



Able Medical


Universal Medical Industry


Able Medical
Full Prescribing Info
Adverse Reactions
Summary of the safety profile: The most commonly reported adverse reactions during treatment are gastrointestinal disturbances and injection site reactions. Other important adverse reactions include hypokalaemia and/or hypernatraemia.
Tabulated list of adverse reactions: Undesirable effects are listed by body system and frequency in accordance with the following classification: Very common: ≥ 1/10; Common: ≥ 1/100 to < 1/10; Uncommon: ≥ 1/1,000 to < 1/100; Rare: ≥ 1/10,000 to < 1/1,000; Very rare: < 1/10,000; Not known: cannot be estimated from the available data. (See Table 6.)

Click on icon to see table/diagram/image

Description of selected adverse reactions: Hypokalaemia may result in diffuse symptoms such as weakness, tiredness or oedema and/or muscle twitching. Severe forms may cause hyporeflexia and cardiac arrhythmia. Hypernatraemia may be associated with hypertension and signs of fluid overload such as oedema (see Precautions).
Paediatric population: Limited safety information is available from the paediatric population. Frequency, type and severity of adverse reactions may be expected to be similar to the adult population.
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in